|
Volumn 15, Issue 20, 2005, Pages 4628-4631
|
9H-Xanthene-9-carboxylic acid [1,2,4]oxadiazol-3-yl- and (2H-tetrazol-5-yl)-amides as potent, orally available mGlu1 receptor enhancers
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,2,4 OXADIAZOLE DERIVATIVE;
9H XANTHENE 9 CARBONYLCARBAMIC ACID BUTYL ESTER;
AMIDE;
CALCIUM;
DIPHENYLACETYLCARBAMIC ACID ETHYL ESTER;
METABOTROPIC RECEPTOR 1;
METABOTROPIC RECEPTOR AGONIST;
UNCLASSIFIED DRUG;
ALLOSTERISM;
CALCIUM CELL LEVEL;
CONFERENCE PAPER;
DECARBOXYLATION;
DRUG BINDING SITE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG BRAIN LEVEL;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG POTENCY;
DRUG SCREENING;
DRUG SYNTHESIS;
EMBRYO;
HUMAN;
HUMAN CELL;
HYDROLYSIS;
PHYSIOLOGY;
PLASMA CLEARANCE;
STRUCTURE ACTIVITY RELATION;
ALLOSTERIC REGULATION;
ANIMALS;
EXCITATORY AMINO ACID AGONISTS;
OXADIAZOLES;
RATS;
RECEPTORS, METABOTROPIC GLUTAMATE;
SPECTROMETRY, FLUORESCENCE;
TETRAZOLES;
|
EID: 24344475655
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2005.05.135 Document Type: Conference Paper |
Times cited : (88)
|
References (16)
|